FIELD: medicine.
SUBSTANCE: method for thrombocyte intravascular activation analysis involving blood sampling, blood cell fixation with ethylene-diamine-tetraacetic acid, centrifugation, and activated thrombocyte detection in the prepared plasma by maximum integrated optical density of all formed units, and if any observed, the intensity of thrombocyte intravascular activation is evaluated.
EFFECT: method provides higher accuracy of thrombocyte intravascular activation analysis.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STUDYING THROMBOCYTE AGGREGATION | 2009 |
|
RU2421724C1 |
| METHOD OF DETERMINING AGREGATIVE ACTIVITY OF PLATELETS AND DEVICE FOR ITS REALISATION | 2008 |
|
RU2391665C1 |
| NOVEL SPECIFIC MECHANISM FOR INHIBITION OF PLATELET ADHESION TO COLLAGEN | 2001 |
|
RU2302880C2 |
| ANTITHROMBOTIC PREPARATION AND METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS | 2002 |
|
RU2205027C1 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| METHOD FOR INVESTIGATING BLOOD PLATELETS ACTIVATION AND AGGREGATION | 1996 |
|
RU2108579C1 |
| AGENT FOR TREATMENT AND PREVENTION OF THROMBOSIS | 2017 |
|
RU2662308C1 |
| PREVENTION OF FORMATION AND/OR STABILISATION OF THROMBI | 2005 |
|
RU2514878C2 |
| APPLICATION OF VALSARTAN OR METABOLITE THEREOF FOR INHIBITION OF THROMBOCYTE AGGREGATION | 2003 |
|
RU2334512C2 |
| METHOD OF IMPAIRED FUNCTIONAL ACTIVITY CORRECTION FOR GLYCOPROTEID THROMBOCYTE RECEPTORS | 2007 |
|
RU2371215C2 |
